Literature DB >> 7579017

Usefulness of the Clinical Dementia Rating scale in screening for dementia.

K Juva1, R Sulkava, T Erkinjuntti, R Ylikoski, J Valvanne, R Tilvis.   

Abstract

The Clinical Dementia Rating (CDR) scale is a qualitative staging instrument that has traditionally been used for assessing the severity of dementia. We used it for screening dementia in a population study of 75-, 80-, and 85-year-old people. The modified CDR scale was easy to establish and it proved to be useful in screening dementia. A more thorough examination is needed in the second phase to identify the false positives. The sensitivity of the CDR scale was 95% and the specificity 94%.

Entities:  

Mesh:

Year:  1995        PMID: 7579017     DOI: 10.1017/s1041610295001815

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  17 in total

1.  Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities.

Authors:  Shanna L Burke; Tianyan Hu; Nicole M Fava; Tan Li; Miriam J Rodriguez; Katie L Schuldiner; Aaron Burgess; Angela Laird
Journal:  J Women Aging       Date:  2018-01-10

2.  Dementia-Related Neuropsychological Testing Considerations in Non-Hispanic White and Latino/Hispanic Populations.

Authors:  Shanna L Burke; Mitra Naseh; Miriam J Rodriguez; Aaron Burgess; David Loewenstein
Journal:  Psychol Neurosci       Date:  2019-03-11

3.  Rate of early onset Alzheimer's disease: a systematic review and meta-analysis.

Authors:  Xi-Chen Zhu; Lan Tan; Hui-Fu Wang; Teng Jiang; Lei Cao; Chong Wang; Jun Wang; Chen-Chen Tan; Xiang-Fei Meng; Jin-Tai Yu
Journal:  Ann Transl Med       Date:  2015-03

4.  Gender, apolipoprotein E genotype, and mesial temporal atrophy: 2-year follow-up in patients with stable mild cognitive impairment and with progression from mild cognitive impairment to Alzheimer's disease.

Authors:  M V Spampinato; B R Langdon; K E Patrick; R O Parker; H Collins; E Pravata'
Journal:  Neuroradiology       Date:  2016-09-02       Impact factor: 2.804

5.  Apolipoprotein E and gray matter volume loss in patients with mild cognitive impairment and Alzheimer disease.

Authors:  Maria Vittoria Spampinato; Zoran Rumboldt; Robert J Hosker; Jacobo E Mintzer
Journal:  Radiology       Date:  2010-12-16       Impact factor: 11.105

6.  Clustering and switching during a semantic verbal fluency test contribute to differential diagnosis of cognitive impairment.

Authors:  Qianhua Zhao; Qihao Guo; Zhen Hong
Journal:  Neurosci Bull       Date:  2013-01-15       Impact factor: 5.203

7.  Apolipoprotein E genotype modifies the association between midlife lung function and cognitive function in old age.

Authors:  Erik J Giltay; Aulikki Nissinen; Simona Giampaoli; Daan Kromhout
Journal:  Dement Geriatr Cogn Disord       Date:  2009-11-10       Impact factor: 2.959

8.  The neural correlates of anomia in the conversion from mild cognitive impairment to Alzheimer's disease.

Authors:  Emanuele Pravatà; Joshua Tavernier; Ryan Parker; Hrvoje Vavro; Jacobo E Mintzer; Maria Vittoria Spampinato
Journal:  Neuroradiology       Date:  2015-09-23       Impact factor: 2.804

9.  Nursing-home residents and their drug use: a comparison between mentally intact and mentally impaired residents. The Bergen district nursing home (BEDNURS) study.

Authors:  Harald A Nygaard; Mala Naik; Sabine Ruths; Jørund Straand
Journal:  Eur J Clin Pharmacol       Date:  2003-08-12       Impact factor: 2.953

Review 10.  Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations.

Authors:  Sam T Creavin; Susanna Wisniewski; Anna H Noel-Storr; Clare M Trevelyan; Thomas Hampton; Dane Rayment; Victoria M Thom; Kirsty J E Nash; Hosam Elhamoui; Rowena Milligan; Anish S Patel; Demitra V Tsivos; Tracey Wing; Emma Phillips; Sophie M Kellman; Hannah L Shackleton; Georgina F Singleton; Bethany E Neale; Martha E Watton; Sarah Cullum
Journal:  Cochrane Database Syst Rev       Date:  2016-01-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.